These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Arterial complications of migraine treatment with methysergide and parenteral ergotamine. Joyce DA; Gubbay SS Br Med J (Clin Res Ed); 1982 Jul; 285(6337):260-1. PubMed ID: 6807440 [No Abstract] [Full Text] [Related]
6. Peripheral arterial insufficiency during ergotamine treatment. Course of disease, angiographical findings, and treatment by phenoxybenzamine. Hessov I; Kromann-Andersen C; Madsen B Dan Med Bull; 1972 Oct; 19(7):236-44. PubMed ID: 5079929 [No Abstract] [Full Text] [Related]
7. Ergotamine tartrate in the treatment of migraine. Wilkinson M; Wall WC Arch Neurobiol (Madr); 1974; 37 SUPPL():317-9. PubMed ID: 4462488 [No Abstract] [Full Text] [Related]
8. [A case of hyposphygmia caused by ergotamine in migraine]. Pulici S; Roncoroni G Minerva Med; 1975 Feb; 66(13):612-6. PubMed ID: 1113911 [No Abstract] [Full Text] [Related]
9. Ergotamine tartrate in migraine and the dangers of overdose. Wall MC Nurs Times; 1972 Dec; 68(50):1585. PubMed ID: 4640242 [No Abstract] [Full Text] [Related]
10. Ergotamine: its use in the treatment of migraine and its complications. Saxena VK; De Deyn PP Acta Neurol (Napoli); 1992 Apr; 14(2):140-6. PubMed ID: 1329442 [TBL] [Abstract][Full Text] [Related]
11. Successful treatment of ergotism with Iloprost--a case report. Piquemal R; Emmerich J; Guilmot JL; Fiessinger JN Angiology; 1998 Jun; 49(6):493-7. PubMed ID: 9631897 [TBL] [Abstract][Full Text] [Related]
12. Mitral and aortic valve disease associated with ergotamine therapy for migraine. Report of two cases and review of literature. Hauck AJ; Edwards WD; Danielson GK; Mullany CJ; Bresnahan DR Arch Pathol Lab Med; 1990 Jan; 114(1):62-4. PubMed ID: 2403780 [TBL] [Abstract][Full Text] [Related]
13. [Benefits and risk of migraine drugs containing ergotamine]. Böhme HR; Dassow H; Ludewig R Z Arztl Fortbild (Jena); 1988; 82(24):1267-71. PubMed ID: 3068929 [No Abstract] [Full Text] [Related]
14. Sodium nitroprusside in the treatment of ergotism. O'Dell CW; Davis GB; Johnson AD; Safdi MA; Brant-Zawadzki M; Bookstein JJ Radiology; 1977 Jul; 124(1):73-4. PubMed ID: 866660 [TBL] [Abstract][Full Text] [Related]
15. [Severe arterial spasm and secondary thromboses of the limbs in chronic ergotism]. Belcastro S; De Blasi A; Berti Donini G; Pavanelli L; Buccoliero C Minerva Med; 1985 Nov; 76(44):2131-4. PubMed ID: 2999645 [TBL] [Abstract][Full Text] [Related]
17. Successful treatment of threatening limb loss ischemia of the upper limb caused by ergotamine. A case report and review of the literature. Safar HA; Alanezi KH; Cinà CS J Cardiovasc Surg (Torino); 2002 Apr; 43(2):245-9. PubMed ID: 11887064 [TBL] [Abstract][Full Text] [Related]
18. Vascular injuries in ergotamine abuse: a case report. Centonze V; Polito BM; Di Bari M; Caporaletti P; Albano O Funct Neurol; 1993; 8(4):265-70. PubMed ID: 8314118 [TBL] [Abstract][Full Text] [Related]
19. [Angiospastic occlusion of the superficial femoral artery by chronic ergotamine intake]. Bogun N; Mathies R; Bäsecke J Dtsch Med Wochenschr; 2011 Jan; 136(1-2):23-6. PubMed ID: 21181611 [TBL] [Abstract][Full Text] [Related]
20. Ergotamine as a possible cause of retroperitoneal fibrosis. Lepage-Savary D; Vallières A Clin Pharm; 1982; 1(2):179-80. PubMed ID: 7185517 [No Abstract] [Full Text] [Related] [Next] [New Search]